iotaMotion
St. Paul, US · Delaware corporation · 3 known investors
iotaMotion develops robotic systems for cochlear implant surgery, assisting otolaryngologists in achieving precision beyond human capability. The company serves surgical teams performing cochlear implant procedures and is headquartered in the United States.
Founders & leadership

Board


Investors · 3
Reported raises · per SEC filings
Form D private placements$23.4M disclosed across 7 rounds · 2017–2026
▶$1.9MraisedMar 2026 · 1 investors · Other Health CareRule 506(b)
- Vinnie BellanteExecutive Officer
- Eric B. TimkoDirector
- Jeff HopkinsDirector
- Michael LobinskyExecutive Officer, Director
- Marie CalabriaExecutive Officer
- Marlan Hansen, MDExecutive Officer, Director
- Costa NikouExecutive Officer
- Mike BushlackExecutive Officer
- Michael CrookDirector
- Wayne WallaceDirector
- Christopher MartinDirector
- Offering amount
- $10M
- Amount sold
- $1.9M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedJan 2025 · 25 investors · Other Health CareRule 506(b)
- Michael LobinskyExecutive Officer, Director
- Christopher MartinDirector
- Marlan Hansen, MDExecutive Officer, Director
- Wayne WallaceDirector
- Michael CrookDirector
- Eric B. TimkoDirector
- Offering amount
- $15M
- Amount sold
- $6.4M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.5MraisedApr 2023 · 56 investors · Other Health CareRule 506(b)
- Michael LobinskyExecutive Officer, Director
- Marlan Hansen, MDExecutive Officer, Director
- Eric B. TimkoDirector
- Offering amount
- $15M
- Amount sold
- $8.5M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedMar 2023 · 47 investors · Other Health CareRule 506(b)
- Eric B. TimkoDirector
- Marlan Hansen, MDExecutive Officer, Director
- Michael LobinskyExecutive Officer, Director
- Christopher Kaufmann, MD MSDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- Proceeds to insiders
- $187.5K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedApr 2021 · 32 investors · Other Health CareRule 506(b)
- Marlan HansenExecutive Officer, Director
- Christopher KaufmannExecutive Officer, Director
- Eric B. TimkoDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Proceeds to insiders
- $187.5K
- First sale
- Feb 2021
- Incorporated
- Corporation, De
- Federal exemptions
- 06b
▶$100KraisedApr 2019 · 1 investors · Other Health CareRule 506(b)
- Christopher Kaufmann, MD MSExecutive Officer, Director
- Eric B. TimkoExecutive Officer, Director
- Marlan Hansen, MDExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $100K
- Proceeds to insiders
- $210.5K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$2.1MraisedOct 2018 · 19 investors · Other Health CareRule 506(b)
- Marlan Hansen, MDExecutive Officer, Director
- Eric B. TimkoDirector
- Christopher Kaufmann, MD MSExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $2.1M
- Minimum investment
- $50K
- Proceeds to insiders
- $230K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCompanies competing with iotaMotion for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Science Foundation | Phase I | 2016 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does iotaMotion do?
- iotaMotion develops robotic systems for cochlear implant surgery, assisting otolaryngologists in achieving precision beyond human capability. The company serves surgical teams performing cochlear implant procedures and is headquartered in the United States.
- Who founded iotaMotion?
- iotaMotion was founded by Marlan Hansen, MD, Marlan Hansen, Christopher Kaufmann.
- Who are iotaMotion's investors?
- iotaMotion's investors include ISA Ventures, Mutual Capital Partners, Next Level Ventures.
- How much funding has iotaMotion raised?
- iotaMotion has disclosed $23.4M raised across 7 rounds.
- Where is iotaMotion headquartered?
- iotaMotion is headquartered in St. Paul, US.